OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
SS-02-13 & 13A, Sky-Pod Square
Puchong Jaya South
Puchong, Selangor 47100
Malaysia
Dr. Chin Yung Koa Dato'sri Chin Yung Kong has 15 years of financial advisory and investment banking experience in his career, completed a number of mergers, acquisitions, special purpose acquisition, initial public offerings, listed the company in private placement, private equity financing, debt financing, PIPE, APO/RTO, IPO and leveraged buyout, financial projection modeling and valuation. QMIS Securities Limited is a securities company licensed by the Securities and Futures Commission (SFC) of Hong Kong (Central Registration Number ARK249). Pursuant to the "Securities and Futures Ordinance" the company is a licensed corporation for Type 1 regulated activities (i.e. dealing in securities). QMIS Asset Management Limited is an asset management company registered and established in Hong Kong with the regulated activities of advising on securities and asset management (Type 4 and Type 9, respectively) issued by Hong Kong Securities and Futures Commission, which enable it to engage in investment consultation and asset management-related businesses. He is the Director and Chairman of Orisun Acquisition Corp listed on Nasdaq on 6/8/2018 SPAC CEO of QMIS International Investment Fund SPC and New Century Fund SPC. Since December 2019 the CEO of QMIS TBS Capital Group Corp..
Timo Strattner is the Group CEO, CFO and Chief Investment Officer. Dr. Strattner is an award-winning merchant banker, private fund manager and mostly known as a financier distinguished for his value driven transactions in primary and secondary capital markets. Dr. Strattner held senior management positions in various Companies in in the financial service industry. Some of his landmark transactions included a 1.5 Billion IPO in Australia, the launch of the alternative immunotherapy division of Affinity Medical as interim CEO and as lead project manager securing capitalization strategies for a Hong Kong-Mexican based social housing construction partnership. Dr. Strattner has distinguished himself as value-added manager. Dr. Strattner holds a Bachelor and a Doctor in Business Administration (DBA).
Not available
Not available
Not available
Not available
Not available